Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Greenslopes
Clinical trial register · Australia

Clinical Trials in Greenslopes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Bristol-Myers Squibb9 Janssen Research & Development, LLC4 Iovance Biotherapeutics, Inc.3 AstraZeneca2 Merck Sharp & Dohme LLC2
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Greenslopes

47 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Camperdown, Chermside, Greenslopes, South Brisbane, Adelaide, Frankston, Murdoch, Nedlands
2026-12-16
Recruiting
Bristol-Myers Squibb
Phase 2
160
Gosford, Westmead, Greenslopes, Heidelberg, Perth
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Camperdown, Westmead, Greenslopes, Adelaide, Clayton, Murdoch
2026-09-08
Recruiting
Primmune Therapeutics, Inc.
Phase 2
48
Waratah, Cairns, Greenslopes, Woolloongabba, Melbourne, Nedlands
2026-07-01
Recruiting
IDEAYA Biosciences
Phase 3
520
Greenslopes, Woodville South, Melbourne, Westmead
2026-01-25
Recruiting
Takeda
Phase 3
183
Kogarah, Douglas, Greenslopes, Adelaide, St Albans, Murdoch, Melbourne
2026-01-14
Recruiting
Contineum Therapeutics
Phase 2
324
Camperdown, Westmead, Chermside, Greenslopes, Heidelberg, Melbourne, Midland, Spearwood
2026-01-08
Active, closed
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
NCT07288203Melanoma (Skin Cancer), Unresectable Melanoma, Metastatic Melanoma
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
24
Greenslopes
2025-11-28
Recruiting
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
NCT07244705Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Immunotherapy
DrugsAvastin·Tislelizumab·Bevacizumab
Anbogen Therapeutics, Inc.
Phase 1/2
66
Liverpool, Macquarie Park, Randwick, Greenslopes, Woodville South, Clayton, Heidelberg, Nedlands
2025-11
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Darlinghurst, Kogarah, Westmead, Greenslopes, Woolloongabba, Carlton, Clayton, East Melbourne
2025-09-22
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Blacktown, Macquarie University, Greenslopes, Melbourne, Murdock
2025-05-13
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Clayton, Coorparoo, Greenslopes, Kogarah, Melbourne, Mitcham, Westmead
2025-04-15
Active, closed
Immutep S.A.S.
Phase 3
756
Elizabeth Vale, Greenslopes, Melbourne, Southport, Subiaco, Tiwi, Waratah, Wollongong
2025-03-21
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Recruiting
Iovance Biotherapeutics, Inc.
Phase 1/2
42
Greenslopes, Nedlands
2025-03-11
Active, closed
Merus B.V.
Phase 3
699
Blacktown, St Leonards, Greenslopes, Melbourne
2024-09-25
Recruiting
AMT-676 in Patients With Advanced Solid Tumors
NCT06400485Advanced Solid Tumors
DrugAMT-676
Multitude Therapeutics Inc.
Early Phase 1
24
Randwick, Macquarie, Greenslopes, Melbourne, Nedlands
2024-06-18
Recruiting
Immunocore Ltd
Phase 3
680
Waratah, Greenslopes, Nedlands, Heidelberg, North Melbourne, Wollstonecraft, Woolloongabba
2024-06-05
Active, closed
Amgen
Phase 3
563
Camperdown, Wollongong, Greenslopes, Adelaide, Clayton, Nedlands
2024-06-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Macquarie University, Greenslopes, Melbourne
2024-05-20
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06326411Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation
Nested Therapeutics, Inc
Phase 1
230
Darlinghurst, Randwick, Greenslopes, Adelaide, Malvern
2024-04-09
Recruiting
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma
DrugsHMBD-001·Cetuximab·Docetaxel
Hummingbird Bioscience
Phase 1/2
398
Sydney, Westmead, Brisbane, Greenslopes, Adelaide, Frankston, Malvern, Perth
2024-02-05
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Campbelltown, Canberra, East Melbourne, Greenslopes, Melbourne
2024-01-17
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Greenslopes, Carlton, Melbourne
2023-12-07
Recruiting
Janssen Research & Development, LLC
Phase 1
355
Greenslopes, Melbourne
2023-11-01
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Heidelberg,VIC
2023-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
684
East Melbourne, Greenslopes, Melbourne, Miranda, Mitcham, Parkville
2023-10-12
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Frankston
2023-09-14
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Greenslopes, Melbourne, Murdoch, Bedford Park, Westmead
2023-03-30
Recruiting
Immunocore Ltd
Phase 3
540
Wollstonecraft, Greenslopes, Woolloongabba, Melbourne
2022-12-19
Active, closed
Sanofi
Phase 2/3
1,856
Westmead, Greenslopes, Carlton, Melbourne, Parkville, Traralgon
2022-08-22
Active, closed
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
NCT05355298Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma
Amplia Therapeutics Limited
Phase 1/2
62
St Leonards, Waratah, Westmead, Greenslopes, Box Hill, Clayton, Richmond, St Albans
2022-05-31
Active, closed
AstraZeneca
Phase 3
1,035
Birtinya, Greenslopes, Kogarah, North Adelaide, Orange, Redcliffe, Wahroonga
2022-03-25
Active, closed
Gilead Sciences
Phase 3
603
Albury, Bowral, Darlinghurst, Birtinya, Greenslopes, Bedford Park, Hobart, Box Hill
2021-11-17
Recruiting
Pfizer
Phase 3
893
Benowa, Clayfield, Greenslopes, Woolloongabba, East Melbourne, Fitzroy, Geelong, Melbourne
2021-10-04
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
DrugsKeytruda·Pembrolizumab
Medicenna Therapeutics, Inc.
Phase 1/2
160
Randwick, Sydney, Buderim, Greenslopes
2021-08-27
Active, closed
Inventiva Pharma
Phase 3
1,000
Concord, Liverpool, Penrith, Greenslopes, Herston, Box Hill, Clayton, Heidelberg
2021-08-19
Active, closed
Bristol-Myers Squibb
Phase 3
790
Waratah, Westmead, Wollstonecraft, Cairns, Greenslopes, Herston, Southport, Box Hill
2019-10-28
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Coffs Harbour, North Sydney, Sydney, Waratah, Westmead, Greenslopes, South Brisbane, Southport
2019-08-09
Active, closed
AstraZeneca
Phase 3
895
Box Hill, Darlinghurst, Greenslopes, Herston, Kingswood, Kurralta Park, St Albans, Waratah
2018-10-31
Active, closed
Exelixis
Phase 3
837
Camperdown, Darlinghurst, Kingswood, Kogarah, Westmead, Greenslopes, Kurralta Park, Box Hill
2018-06-10
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
North Sydney, Waratah, Greenslopes, Southport, Bedford Park, Murdoch
2018-04-11
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Wollongong, Benowa, Buderim, Greenslopes, South Brisbane, Woolloongabba, Box Hill, Malvern
2017-09-20
Active, closed
Eli Lilly and Company
Phase 1
223
Newcastle, Sydney, Greenslopes
2016-11-21
Active, closed
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
DrugsLevonorgestrel·Mirena·Metformin
Queensland Centre for Gynaecological Cancer
Phase 2
165
Camperdown, Auchenflower, Brisbane, Greenslopes, South Brisbane, Southport, Townsville, Adelaide
2012-12
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/greenslopes

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Greenslopes.

How many clinical trials are recruiting in Greenslopes?

23 of the 47 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 23 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Greenslopes), 47 studies
PhaseStudiesRecruitingShare
Phase 3281159.6%
Phase 1/26512.8%
Phase 26412.8%
Phase 1428.5%
Phase 2/3204.3%
Early Phase 1112.1%

Most active sponsors

Lead sponsors with the most studies (Greenslopes)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb94
Janssen Research & Development, LLC41
Iovance Biotherapeutics, Inc.32
AstraZeneca20
Immunocore Ltd22
Merck Sharp & Dohme LLC22
89bio, Inc.11
Amgen10
Amplia Therapeutics Limited10
Anbogen Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.